Mar Giner-Calabuig

Mar Giner-Calabuig is an Associate Research Scientist at the Yale School of Medicine's Department of Digestive Diseases. She holds a PhD from the University of Alicante (2020), an MS in Biology and Clinics of Cancer from the University of Salamanca (2015), and a BA in Biomedical Sciences from the University of Lleida (2014). Her research focuses on colorectal cancer genetics, Lynch syndrome mechanisms, and biomarker development for early cancer detection. Notable work includes validating the NCCN/Yale criteria for CDH1 genetic testing and exploring volatile organic compounds as non-invasive diagnostic tools. Her studies on mismatch repair-deficient tumors and Lynch-like syndrome have advanced clinical management strategies and familial cancer risk assessment.

Research interests include genomic and epigenetic drivers of hereditary cancers, molecular classification of tumors, and translational applications of biomarkers. Collaborations with teams like the Stephen & Denise Adams Center for Parkinson’s Disease Research highlight interdisciplinary approaches to cancer research. No awards are explicitly listed, but her extensive publication record reflects contributions to clinical and molecular oncology.

Advising and grants are not detailed here, though her role in high-impact studies suggests active participation in funded research projects. Her work is part of Yale’s broader efforts in gastrointestinal oncology and precision medicine.